Transplantation/ImmunologyCordyceps sinensis Extracts Attenuate Aortic Transplant Arteriosclerosis in Rats
Introduction
Although advances in immunosuppressive therapies have dramatically increased clinical organ transplantation success rates, transplant arteriosclerosis presentation has become a major obstacle in long-term allograft survival, a major cause of late allograft dysfunction and late death in some patients [1]. Therefore, developing new therapies aimed at attenuating transplant arteriosclerosis is critical. Cordyceps sinensis (the Chinese caterpillar fungus) is a highly valued medicinal fungus used in Chinese herbal medicine that has been used in tonics to increase longevity, endurance, and vitality, and its medicinal value has gained worldwide attention in recent years 2, 3. C. sinensis has been shown to have multiple pharmacologic activities, including antiproliferative activities on a variety of tumor cells [4]. Recently, it has also been shown that C. sinensis inhibited the migration and proliferation of VSMC (vascular smooth muscle) and neointima formation [5]. Although these data suggest that C. sinensis possess properties that may affect vascular diseases 5, 6, a defined mechanism for C. sinensis in mediating transplant arteriosclerosis success has not been established. The present study was designed to determine the effects of C. sinensis on the success of transplant arteriosclerosis in a rat model, as well to define potential molecular mechanisms.
Section snippets
Animals
Inbred male BN (Brown-Norway) and Lewis rats weighing between 250 and 300 g were purchased from Beijing Vital River Laboratory. Rats had access to standard rat chow and water ad libitum and were maintained following conditions established by the Guide for the Care and Use of Laboratory Animals.
Cordyceps sinensis Extracts Preparation
C. sinensis was obtained from the Zhongmei Huadong Company (Hangzhou, China). C. sinensis and asexual phase Histutella sinensis isolates were cultured in hydrolysable nutrient media at 15°C for 45 d to
Effect of C. sinensis on Neointimal Thickness
When recipient rats were treated daily with 0.5 mg/kg C. sinensis, neointimal thickness was significantly decreased compared to untreated controls (8.27 ± 1.95 μm versus 11.42 ± 2.67 μm, P < 0.05; Fig. 1). Daily treatment with 1 mg/kg, 2 mg/kg or 5 mg/kg C. sinensis also significantly reduced neointimal thickness compared thickness observed in untreated controls (neointimal thickness of 3.69 ± 1.43 μm [1 mg/kg], 3.78 ± 1.65μm [2 mg/kg], 3.66 ± 1.58 μm [5 mg/kg] versus 11.42 ± 2.67 μm [control];
Discussion
Although currently used immunosuppressive regimens are highly effective in preventing acute rejection, there are no adequate therapies available to prevent or treat chronic transplant disease. The most common histopathologic hallmark of chronic transplant disease is transplant arteriosclerosis 8, 9. Immunosuppressive treatments based on calcineurin inhibition (cyclosporine, tacrolimus), as well as newer second messenger inhibitors such as the mammalian target of rapamycin (mTOR) inhibitors
Acknowledgments
This work was supported by the Zhejiang Provincial Top Key Discipline in Surgery.
References (33)
- et al.
Cardiac allograft remodeling after heart transplantation is associated with increased graft vasculopathy and mortality
Am J Transplant
(2009) - et al.
Cordycepin inhibits vascular smooth muscle cell proliferation
Eur J Pharmacol
(2008) Cordyceps: A traditional Chinese medicine and another fungal therapeutic biofactory?
Phytochemistry
(2008)- et al.
Role of progenitor cells in transplant arteriosclerosis
Trends Cardiovasc Med
(2005) - et al.
Current understanding and management of allograft vasculopathy
Semin Thorac Cardiovasc Surg
(2004) - et al.
Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: Influence on inflammation and progression of intimal hyperplasia
J Heart Lung Transplant
(2004) - et al.
Effects of mycophenolate mofetil on cardiac allograft survival and cardiac allograft vasculopathy in miniature swine
Ann Thorac Surg
(2005) - et al.
Preventing cardiac allograft vasculopathy: Long-term beneficial effects of mycophenolate mofetil
J Heart Lung Transplant
(2006) - et al.
Cryptotanshinone from Salvia miltiorrhiza Bunge has an inhibitory effect on TNF-α-induced matrix metalloproteinase-9 production and HASMC migration via down-regulated NF-κB and AP-1
Biochem Pharmacol
(2006) - et al.
Cytokines and chemokine gene expression in human kidney transplantation
Transplant Proc
(2005)